The DOI matches its Crossref record.
The Inhibition of Islet Superoxide Dismutase by Diabetogenic Drugs
Abstract
The enzyme superoxide dismutase (SOD) is a scavenger of superoxide radicals and protects the integrity of cell membranes. We previously reported that streptozotocin inhibits the SOD activity of erythrocytes and retinae in vivo and in vitro. We now report that the three major diabetogenic drugs, i.e., alloxan, streptozotocin, and Vacor (in order of increasing potency), interact with erythrocyte Cu-Zn SOD in vitro. Maximum inhibition of erythrocyte SOD of man, dog, rat, and cow is 40% and is achieved within 10 min. At submaximal doses the effect of the three drugs is additive. Inhibition induced by streptozotocin, but not by the other two agents, is reversible by dialysis. Alloxan (80 mg/kg), like streptozotocin, also inhibits erythrocyte SOD activity when injected i.v. into rats. Glucose or 3- o-methylglucose does not prevent SOD inhibition by alloxan or streptozotocin in vitro. Injection of glucose before alloxan prevents the development of diabetes, but does not prevent alloxan-lnduced inhibition of erythrocyte SOD. SOD is present in the islets of Langerhans of rats and dogs, as demonstrated by biochemical assay of isolated islets and by immunofluorescent staining of frozen pancreases. The specific activity of SOD in the islets exceeds that of the exocrine pancreas more than 100-fold. The islet SOD is of the Cu-Zn type, since it is inhibited by KCN, and not by chloroformethanol. The mobility of the islet enzyme on polyacrylamlde disc gel electrophoresis is different from that of erythrocyte SOD. Streptozotocin, alloxan, and Vacor Inhibit the activity of islet SOD in vitro; the rate and magnitude of inhibition is the same as that observed with erythrocyte SOD. The Mn SOD of liver mitochondria is not affected by the diabetogenic drugs. It is suggested that the inhibitory effect of the diabeto- genie drugs on islet cell SOD may contribute to their cytotoxicity, and that changes in the amount or activity of this protective enzyme in β-cells may play a role in determining their vulnerability to noxious agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Oberley, L. W. (1988) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(88)90036-6 · Cited by 1,105
Borgstahl, G. E. O., Parge, H. E., Hickey, M. J., Beyer, W. F., Hallewell, R. A., & Tainer, J. A. (1992) · Cell · doi:10.1016/0092-8674(92)90270-m · Cited by 472
Monteiro, D. A., de Almeida, J. A., Rantin, F. T., & Kalinin, A. L. (2006) · Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology · doi:10.1016/j.cbpc.2006.01.004 · Cited by 384
6 Copper Complexes Offer a Physiological Approach to Treatment of Chronic Diseases
Sorenson, J. R. J. (1989) · Progress in Medicinal Chemistry · doi:10.1016/s0079-6468(08)70246-7 · Cited by 324
Hershko, C., Weatherall, D. J., & Finch, C. (1988) · CRC Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408368809105894 · Cited by 141
Metadata
- Authors
- Crouch, R. K., Gandy, S. E., Kimsey, G., Galbraith, R. A., Galbraith, G. M. P., & Buse, M. G.
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 1981-03-01
- Volume
- 30
- Issue
- 3
- Pages
- 235-241
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2168428117
- Cited by
- 223
- References
- 0
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Inhibition of Islet Superoxide Dismutase by Diabetogenic Drugs. https://app.cochat.ai/papers/10.2337/diab.30.3.235
- The paper
- Crouch, R. K., Gandy, S. E., Kimsey, G., Galbraith, R. A., Galbraith, G. M. P., & Buse, M. G. (1981). The Inhibition of Islet Superoxide Dismutase by Diabetogenic Drugs. Diabetes. https://doi.org/10.2337/diab.30.3.235
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.